4//SEC Filing
GORMAN KEVIN CHARLES 4
Accession 0000914475-25-000132
CIK 0000914475other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 5:29 PM ET
Size
5.2 KB
Accession
0000914475-25-000132
Insider Transaction Report
Form 4
GORMAN KEVIN CHARLES
DirectorPresident & CEO
Transactions
- Award
Non-Qualified Stock Option
2025-05-21+6,610→ 6,610 totalExercise: $120.56Exp: 2035-05-21→ Common Stock (6,610 underlying)
Footnotes (1)
- [F1]Option vests in 12 monthly installments beginning June 21, 2025.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001201096
Filing Metadata
- Form type
- 4
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 5:29 PM ET
- Size
- 5.2 KB